Epithelial to mesenchymal transition is associated with rapamycin resistance

Authors

Ashley M. Holder, Washington University School of Medicine in St. Louis
Argun Alcakanat, The University of Texas MD Anderson Cancer Center
Farrell Adkins, Cleveland Clinic Florida
Kurt Evans, The University of Texas MD Anderson Cancer Center
Huiqin Chen, The University of Texas MD Anderson Cancer Center
Caimiao Wei, The University of Texas MD Anderson Cancer Center
Denai R. Milton, The University of Texas MD Anderson Cancer Center
Yisheng Li, The University of Texas MD Anderson Cancer Center
Kim-Anh Do, The University of Texas MD Anderson Cancer Center
Filip Janku, The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, The University of Texas MD Anderson Cancer Center

Journal

Oncotarget

Publication Date

2015

Volume

6

Issue

23

Inclusive Pages

19500-13

Document Type

Open Access Publication

Rights and Permissions

Holder, A., Akcakanat, A., Adkins, F., Evans, K., Chen, H., Wei, C., Milton, D., Li, Y., Do, K., Janku, F., & Meric-Bernstam, F. (2015). Epithelial to mesenchymal transition is associated with rapamycin resistance. Oncotarget, 6(23), 19500-19513. Copyright: © Holder et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Holder, Ashley M.; Alcakanat, Argun; Adkins, Farrell; Evans, Kurt; Chen, Huiqin; Wei, Caimiao; Milton, Denai R.; Li, Yisheng; Do, Kim-Anh; Janku, Filip; and Meric-Bernstam, Funda, "Epithelial to mesenchymal transition is associated with rapamycin resistance." Oncotarget. 6, 23. 19500-13. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4144